Effect of methylglyoxal bis(guanylhydrazone) on S-adenosylmethionine decarboxylase in the isolated perfused rat liver  by Pegg, Anthony E. & Jefferson, Leonard S.
Volume 40, number 2 FEBS LETTERS April 1974 
EFFECT OF METHYLGLYOXAL BIS(GUANYLHYDRAZONE)* ON 
S-ADENOSYLMETHIONINE DECARBOXYLASE IN THE ISOLATED PERFUSED RAT 
LIVER 
Anthony E. PEGG 
Courtauld Institute of Biochemistry, Middlesex HospitalMedical School, London WIP, England 
and 
Leonard S. JEFFERSON 
Dept. of Physiology, The Milton S. Hershey Medical Center, Pennsylvania State University, 
Hershey, Pa. 17033, USA 
Received 16 January 1974 
1. Introduction 
S-Adenosylmethionine decarboxylase (E.C. 
4.1 .I SO) is a key enzyme in the biosynthetic path- 
way leading to polyamines [l-7] . The possibility 
that information as to the biological role of poly- 
amines might be obtained by inhibition of the activi- 
ty of this enzyme was raised by the discovery that 
methylglyoxal bis(guanylhydrazone) (MGBG) is a 
very potent but reversible inhibitor of mammalian 
Sadenosylmethionine d carboxylases [ 1] . However 
studies of the effects of this inhibitor in vivo have 
revealed that its administration leads to a large in- 
crease in the amount of S-adenosylmethionine d car- 
boxylase activity present in various tissues when ex- 
tracts are assayed removal of any residual inhibitor 
[2-51. This finding coupled with the toxicity and 
rate of excretion of the drug has prevented the use of 
MGBG to investigate the role of polyamines in intact 
animals, although studies of the effects of MGBG on 
cells in culture have proved more rewarding [S-7]. 
The mechanism by which a large increase in the ac- 
tivity of an enzyme inhibited by MGBG is produced 
by administration of the drug is of considerable inter- 
est particularly since MGBG is a useful antileukaemic 
agent [8]. The present paper eports studies of the 
* The correct chemical name for this drug is l,l’- [ (methyl- 
ethanediylidene)-dinitrilo] diguanidine. 
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effects of MGBG on S-adenosylmethionine d carbox- 
ylase activity in the isolated perfused liver. Perfusion 
of the liver with a medium containing MGBG led to 
an increase in the activity of S-adenosylmethionine 
decarboxylase and prevented the loss of enzyme ac- 
tivity produced by cycloheximide, but perfusion with 
putrescine was ineffective in these respects. These 
results indicate that the increased S-adenosylmethio- 
nine decarboxylase activity produced by the inhibitor 
may be due to stabilisation of the enzyme against 
intracellular degradation by combination with the 
inhibitor. They also rule out the possibility that the 
increased concentrations of putrescine (which is an 
activator of the S-adenosylmethionine d carboxylase) 
brought about by MGBG are responsible for the in- 
creased enzyme activity. 
2. Methods 
Male Wistar ats weighing 100-I 15 g were used in 
all experiments. Livers were perfused in situ as pre- 
viously described [9] . The basic perfusion medium 
consisted of Krebs-Henseleit bicarbonate buffer 
containing 3% (w/v) bovine serum albumin, 8 mM 
glucose, sufficient washed bovine erythrocytes to give 
a hematocrit of 20-22%, and unless indicated other- 
wise a mixture of 20 amino acids at ten times their 
concentration i  normal rat plasma. The perfusate 
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was equilibrated with humidified 02-CO2 (95%:5%) 
at 37°C in rotating reservoirs and pumped through 
the liver at a constant rate of 7.0 ml/mm. 
S-Adenosylmethionine d carboxylase and orni- 
thine decarboxylase activity were determined as pre- 
viously described [ 10, 1 l] . Extracts from tissues 
which had been treated with MGBG were dialysed to 
remove any residual inhibitor [3] and all assays were 
conducted under conditions where the measured 
activity was proportional to the amount of tissue 
protein added and to the tune of incubation. 
Putrescine concentrations were determined by 
extraction of frozen tissue samples and electropho- 
retie separation of the amines present [111. The re- 
covery of putrescine during the extraction was moni- 
tored by the addition of trace amounts of radioactive 
putrescine to the extracts and was 80-90%. The 
values given were corrected for this loss. 
3. Results and discussion 
There was little change in the S-adenosylmethio- 
nine decarboxylase activity of livers perfused for 3 hr 
under standard conditions (table 1). However, if
MGBG (0.1 mM) was present in the perfusion me- 
dium and the activity of the enzyme was assayed in 
tissue extracts which had been dialysed in order to 
remove the inhibitor, the activity was doubled within 
the 3 hr perfusion period. This result is in agreement 
with previous experiments where MGBG was admin- 
istered to rats [2-4]. Such changes observed in rats 
in vivo might be mediated through some alterations in 
hormone levels brought about by MGBG since S- 
adenosylmethionine d carboxylase activity is known 
to be regulated by a variety of hormonal factors [9, 
lo] . However, it is unlikely that the inhibitor could 
bring about changes by such a mechanism in the iso- 
lated perfused liver. 
Mammalian S-adenosylmethionine decarboxylases 
are known to be activated by putrescine [lo] . Pu- 
trescine is formed in mammalian tissues by the action 
of ornithine decarboxylase and is converted into 
spermidine by the action of spermidine synthetase 
which uses decarboxylated S-adenosylmethionine as a 
source of the propylamine moiety needed for conver- 
sion of putrescine into spermidine [ 1 O-l 21. When 
production of decarboxylated S-adenosylmethionine 
is blocked by MGBG, putrescine cannot be converted 
into spermidine and accumulates [2,4,6,7]. Since 
putrescine is an activator of mammalian S-adenosyl- 
methionine decarboxylases and stabilises the enzyme 
in vitro against attack by proteolytic enzymes [3] , it 
is possible that the increased levels of putrescine re- 
sulting from treatment with MGBG lead to the in- 
creased activity of S-adenosylmethionine decarboxyl- 
ase. However, as shown in table 1, perfusion of the 
liver with putrescine (6.2 mM) for 3 hr did not lead 
to an increase in the Sadenosylmethionine d carbox- 
ylase activity although this treatment did produce a 
Table 1 
Effect of perfusion with MGBG or putrescine on activity of S-adenosylmethionhre d carboxylase and putrescine concentration in 
rat liver 
S-Adenosyhnethionine Putrescine 
decarboxylase activity content 
(nmole COs/hr/g wet wt.) (nmole/g wet wt.) 
Control (not perfused) 42.5 i 1.2 (34) 33 f 3 (4) 
Perfused for 3 hr 38.1 f 1.2 (8) 32 f 2 (5) 
Perfused for 3 hr 
+ 0.1 mM MGBG 83.0 i 2.3 (5) 48 f 6 (3) 
Perfused for 3 hr 
+ 6.2 mM putrescine 43.2 i 2.0 (3) 742 f 28 (3) 
Results are given f S.E.M. for the number of estimations hown. After perfusion of the livers with putrescine, the intracellular put- 
rescine content of the liver was determined after a 10 min perfusion without putrescine in order to wash out extracellular putrescine. 
This procedure was shown to be effective by measurement of the loss from the liver of q3H] putrescine. After 5 mm of wash out, 
radioactivity of the effluent perfusate had fallen to less than 1% of that present during the recirculation period (2 rCi/ml) and by 
10 min virtually no radioactivity was detectable in the effluent. 
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very substantial rise in the liver putrescine content. It 
is therefore unlikely that an increase in the intracellu- 
lar putrescine concentration can be responsible for 
the MGBG-mediated increase in S-adenosylmethio- 
nine decarboxylase activity. 
This interpretation is supported by analysis of the 
putrescine content of the livers perfused with MGBG 
(table 1). There was only a small increase in the con- 
centration of putrescine during the perfusion al- 
though the S-adenosylmethionine d carboxylase ac- 
tivity was doubled. Considerably greater increases in 
liver putrescine content were observed 8 and 20 hr 
after administration of the inhibitor in vivo [2] but 
cannot be directly compared to the present results 
since the time of perfusion was only 3 hr. Also the 
fact that ornithine decarboxylase activity declines 
very sharply after perfusion of the liver is started and 
only slowly recovers (unpublished ata) may prevent 
greater accumulation of putrescine during the perfu- 
sion with MGBG. 
S-Adenosylmethionine d carboxylase activity is 
rapidly lost after the application of inhibitors of pro- 
I 00 ,120 
PERFUSION (min) 
Fig. 1. Loss of activity of Sadenosylmethionine decarboxyl- 
ase and omithine decarboxylase after perfusion in the pres- 
ence of cycloheximide. The perfusion medium contained 
0.1 mM cycloheximide but no amino acids. Results are 
shown for S-adenosyhnethionine decarboxylase activity in 
extracts from livers perfused with no addition (=), 0.1 mM 
MGBGB (0) and 6.2 mM putrescine (A). Omithine decarbox- 
ylase activity is presented for perfusions with no addition (o) 
and 0.1 mM MGBG (0). 
tein synthesis to intact animal or cells in culture [3, 
5,12,13] . A similar apid decline in the activity of 
this enzyme is seen after perfusion in the presence of 
cycloheximide (fig. 1). The apparent half-life of liver 
S-adenosylmethionine decarboxylase measured in this 
way is 65 min which is in reasonable agreement with 
that found in rat liver in vivo [ 131. Perfusion in the 
presence of putrescine had no effect on the rate of 
loss of S-adenosylmethionine decarboxylase activity 
suggesting that the change in the intracellular content 
of putrescine from about 32 nmoleslg wet wt. to 
742 nmoles/g wet wt. did not alter the rate of degra- 
dation of the enzyme to an inactive form. In contrast 
the inclusion of MGBG in the perfusion medium al- 
most completely prevented the loss of activity during 
a 3 hr perfusion in the presence of cycloheximide 
(fig. 1). This effect was not due to a generalised in- 
hibition of protein degradation by MGBG since omi- 
thine decarboxylase activity which is also rapidly lost 
on perfusion of the liver with cycloheximide declined 
at a similar ate in the presence or absence of MGBG 
0%. 1). 
These results indicate that MGBG can bring about 
an increase in S-adenosylmethionine decarboxylase 
activity in the isolated perfused liver and that this 
increase is not mediated through hormonal influences 
or through an increase in the tissue putrescine l vel. 
Although considerable care must be taken in equating 
changes in enzyme activity with changes in the 
amount of enzyme protein actually present, in many 
of the cases where this has been investigated by both 
methods the loss of enzyme activity seen in the pres- 
ence of inhibitor has been found to correspond to 
changes in protein content [14] . In the present situa- 
tion this remains to be established but the hypothesis 
that MGBG brings about the increase in S-adenosyl- 
methionine decarboxylase activity by combining with 
the enzyme in such a way as to diminish the rate of 
degradation of the enzyme protein remains the most 
likely explanation of these results. The system de- 
scribed may therefore be of value in studying the 
processes underlying cellular protein degradation 
mechanisms. 
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